由中科大少年班走出的“90后”掌舵！国仪量子估值近百亿

Core Viewpoint - Guoyi Quantum has successfully broken the foreign monopoly in high-end scientific instruments and is planning an IPO on the Sci-Tech Innovation Board to support the localization of high-end scientific instruments in China [1]. Group 1: Company Overview - Guoyi Quantum, established in December 2016, is recognized as a national-level specialized and innovative "little giant" enterprise and was included in the list of Chinese unicorn companies in 2024 [5]. - The company focuses on the research and development of high-end scientific instruments, providing essential equipment for quantum technology, materials science, chemical engineering, biomedicine, and advanced manufacturing [10]. - Guoyi Quantum has developed products that have broken the long-standing monopoly of international giants in certain segments of the domestic instrument market, achieving performance metrics that meet or exceed international competitors [10]. Group 2: Leadership and Control - The actual controllers of Guoyi Quantum are He Yu and Rong Xing, who collectively control 34.87% of the voting rights through various indirect holdings [3]. - He Yu, a notable figure from the University of Science and Technology of China (USTC), has held multiple leadership roles and has been recognized with various awards for his contributions to the industry [4]. - Rong Xing, also a USTC alumnus, has a distinguished academic background and has served in various significant positions within the scientific community [4]. Group 3: Financial Performance - Guoyi Quantum's revenue has shown significant growth, with figures of 151.45 million, 400 million, 501 million, and 171 million yuan for the years 2022 to 2025, reflecting year-on-year growth rates of 163.78% and 25.49% for 2023 and 2024 respectively [13]. - Despite the revenue growth, the company has not yet achieved profitability, with net losses reported at -168 million, -169 million, -104 million, and -74 million yuan for the same period [14]. - The company anticipates turning a profit in 2026, contingent on factors such as product strength, market expansion, and cost control [15]. Group 4: Market Position and Competition - The scientific instrument market has been dominated by international firms like Thermo Fisher, Danaher, and Agilent, which have established a strong presence over decades [16]. - Domestic manufacturers, including Guoyi Quantum, are gradually gaining recognition and breaking the monopoly of these international giants through technological advancements [16]. - Guoyi Quantum faces challenges in enhancing brand recognition and overcoming market penetration barriers due to the long-standing dominance of foreign brands [16][17].